Update on non-alcoholic fatty liver disease in children

Area of Science:

• Hepatology
• Pediatric Gastroenterology
• Metabolic Disorders

Background:

• Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver condition in children, strongly associated with obesity and insulin resistance.
• NAFLD can progress to non-alcoholic steatohepatitis (NASH), characterized by fat accumulation, inflammation, and fibrosis in the liver.
• While imaging confirms NAFLD, liver biopsy is essential for staging the disease's severity.

Purpose of the Study:

• To provide a comprehensive overview of pediatric NAFLD.
• To summarize current knowledge on prevalence, pathogenesis, diagnostic methods, histological features, and treatment strategies.

Main Methods:

• Literature review of existing studies on pediatric NAFLD.
• Synthesis of information regarding epidemiology, etiology, and clinical presentation.
• Analysis of diagnostic modalities including imaging and liver biopsy.
• Review of current and emerging therapeutic interventions.

Main Results:

• NAFLD is a growing concern in pediatric populations, closely mirroring adult trends in metabolic associations.
• Diagnostic challenges exist, with imaging aiding detection but biopsy crucial for accurate staging.
• Weight management and lifestyle changes are primary treatments, with pharmacologic options under investigation.

Conclusions:

• Pediatric NAFLD requires further research into its long-term outcomes and optimal management strategies.
• Early detection and intervention are critical to prevent disease progression and potential complications.
• Multidisciplinary approaches involving healthcare providers and families are essential for effective treatment.